Hi Helen
Thanks for your update on the Product License (PL) for Kenalog. I had a long correspondence with Squib over 10 years ago about this and they admitted their product was not licensed for intrathecal use. Eventually they did put a contra-indication (in the PL) re arachnoiditis (much the same as Depo-Medrone had always done). However I then got a very irate letter from a sports doctor telling me I was hindering his private practice by insisting on this warning! He then arrogantly sent me a research report saying they was no problems with ESI's. I was really intrigued by the quote on page 14 "from my recollections of over 25,000 ESI's there were no adverse reactions". So that's all right then! Oh? Authors? Same doctor and a colleague. Funded by? Bristol, Myers, Squib. Cost? £25,000. Not a bad price to pay for their conscience, Squib.
I am not medically qualified to advise anyone on any treatment. What I normally say is ask your consultant, or better still, his secretary - the name of the product and is it licensed? Mind you, if do that be prepared to have that treatment option immediately withdrawn.
Bye for now
Kim